224 related articles for article (PubMed ID: 16817784)
1. LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis.
Kobayashi S; Oka M; Moriya H; Maesato K; Okamoto K; Ohtake T
Ther Apher Dial; 2006 Jun; 10(3):219-23. PubMed ID: 16817784
[TBL] [Abstract][Full Text] [Related]
2. LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects.
Kobayashi S; Moriya H; Maesato K; Okamoto K; Ohtake T
J Clin Apher; 2005 Dec; 20(4):239-43. PubMed ID: 15880405
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
4. LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb.
Kobayashi S; Moriya H; Negishi K; Maesato K; Ohtake T
J Clin Apher; 2003; 18(3):115-9. PubMed ID: 14569601
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
7. Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patients.
Tsurumi-Ikeya Y; Tamura K; Azuma K; Mitsuhashi H; Wakui H; Nakazawa I; Sugano T; Mochida Y; Ebina T; Hirawa N; Toya Y; Uchino K; Umemura S
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1058-65. PubMed ID: 20203302
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial].
Suckfüll M; Seidel D; Thiery J; Mazurek B; Jaehne M; Gronemeyer J; Reichel O; Sasama J; Kichigina S; Möller M; Beil FU; Schrameyer-Wernecke A; Kassner U; Koch M; Jaeger B; Osterkorn K; Osterkorn D
Z Kardiol; 2003; 92(Suppl 3):III59-63. PubMed ID: 14663604
[TBL] [Abstract][Full Text] [Related]
9. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
10. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
Otto C; Berster J; Otto B; Parhofer KG
J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
[TBL] [Abstract][Full Text] [Related]
11. Elevated white blood cell count, CRP and fibrinogen levels are not associated with increased anti-endothelial and anti-ox-LDL antibody, MCP-1, and RANTES levels in early onset occlusive carotid artery disease.
Magyar MT; Bereczki D; Csípo I; Gyimesi E; Csiba L; Valikovics A; Balla J; Sipka S
Cytokine; 2007 Jan; 37(1):44-50. PubMed ID: 17382553
[TBL] [Abstract][Full Text] [Related]
12. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
[TBL] [Abstract][Full Text] [Related]
13. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.
Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J;
Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783
[TBL] [Abstract][Full Text] [Related]
14. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
15. Effect of different LDL-apheresis methods on parameters involved in atherosclerosis.
Hershcovici T; Schechner V; Orlin J; Harell D; Beigel Y
J Clin Apher; 2004; 19(2):90-7. PubMed ID: 15274202
[TBL] [Abstract][Full Text] [Related]
16. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein apheresis for haemodialysis patients with peripheral arterial disease reduces reactive oxygen species production via suppression of NADPH oxidase gene expression in leucocytes.
Hara T; Kiyomoto H; Hitomi H; Moriwaki K; Ihara G; Kaifu K; Fujita Y; Higashiyama C; Nishiyama A; Kohno M
Nephrol Dial Transplant; 2009 Dec; 24(12):3818-25. PubMed ID: 19617260
[TBL] [Abstract][Full Text] [Related]
18. Shear stress-dependent platelet function after LDL cholesterol apheresis.
Spieker LE; Ruschitzka F; Badimon JJ; Noll G; Corti R
Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
[TBL] [Abstract][Full Text] [Related]
19. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]